Midwest Immunology

Plymouth, Minnesota 55446

0 studies enrolling now · 3 studies all time

What they study most

Primary Immunodeficiency, Primary Immunodeficiency Diseases (PID)

Studies at this site

• An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID) — Completed
• Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD — Completed
• Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency — Completed